Neuroscience
Parkinson's Disease
100%
Gene
53%
Brain
41%
In Vivo
39%
Adeno-Associated Virus
33%
Neuron
30%
Adeno Associated Virus Vector
21%
Dopaminergic Neuron
20%
L-DOPA
16%
Tyrosine Hydroxylase
16%
Dopaminergic
16%
Striatum
15%
Neurodegenerative Disorder
14%
Stem Cell
13%
Green Fluorescent Protein
12%
Stereotypic Movement Disorder
12%
Midbrain
10%
Dyskinesia
8%
Basal Ganglia
8%
Forebrain
7%
Hypothalamus
7%
Positron Emission Tomography
7%
Neurological Disorder
7%
In Vitro
6%
Neurodegeneration
6%
Behavior (Neuroscience)
6%
Huntingtin
5%
Posttraumatic Stress Disorder
5%
Protein Aggregation
5%
Embryonic Stem Cell
5%
Cognitive Disorders
5%
Deconvolution
5%
Interneuron
5%
Raclopride
5%
Psychometrics
5%
Cytoskeleton
5%
Intracranial Tumor
5%
Glia
5%
Transcriptomics
5%
Central Nervous System
5%
Biochemistry, Genetics and Molecular Biology
Virus Vector
19%
Capsid
17%
Enzyme
15%
Gene Therapy
13%
Synthesis
11%
Protein
10%
Dose
9%
Clinical Trial
9%
Dopamine
8%
Adeno Associated Virus
8%
RNA
6%
Messenger RNA
6%
Rat
6%
Gene
5%
Rat Model
5%
Fluorescence Resonance Energy Transfer
5%
Screening
5%
P38 Mitogen-Activated Protein Kinases
5%
Neuronal Activity
5%
Defence Mechanisms
5%
Cholinergic
5%
Hematopoietic Stem Cell
5%
Synuclein
5%
RNA Interference
5%
Small Hairpin RNA
5%
Stem Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
61%
Viral Vector
21%
Dopamine
20%
DOPA
18%
Primate
9%
Clinical Trial
9%
Guanosine Triphosphate Cyclohydrolase I
8%
Levodopa
7%
Huntington Chorea
6%
Raclopride C 11
5%
Motor Dysfunction
5%
Cholinergic Receptor Stimulating Agent
5%
Receptor
5%
Neoplasm
5%
Intracranial Tumor
5%
Glioblastoma
5%
Primary Tumor
5%
Dopamine Receptor Stimulating Agent
5%
